ARTICLE | Management Tracks
Plus: Lange becomes CBO of Avidity and updates from CABS, BIO, Zevra and Achieve
By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst
December 10, 2024 1:18 AM UTC
Daiichi Sankyo Co. Ltd. (Tokyo:4568) announced the sudden passing of Executive Officer, Head of Research Toshinori Agatsuma, who led the team that invented the company’s antibody-drug conjugate (ADC) technology. .
“Dr. Agatsuma was a true scientific trailblazer who passionately believed that antibody-based therapies were the future of medicine, which sparked the transformation of Daiichi Sankyo into a global company with competitive advantage in oncology,” Executive Chairman and CEO Sunao Manabe said in a statement…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/654419/toshinori-agatsuma-daiichi-s-head-of-research-passes-away